We are live on ! Find out more
BCTXW

BriaCell Therapeutics Corp Warrant
BCTXW

Delisted

BCTXW was delisted on the 26th of February, 2026.

Back to rankings

5 hedge funds and large institutions have $1.57M invested in BriaCell Therapeutics Corp Warrant in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more funds holding

Funds holding: 4 → 5 (+1)

0.73% less ownership

Funds ownership: 4.79% → 4.05% (-0.73%)

28% less capital invested

Capital invested by funds: $2.19M → $1.57M (-$622K)

92% less call options, than puts

Call options by funds: $42K | Put options by funds: $545K

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
–
Calls
$42K
Puts
$545K
Net Calls
-$503K
Net Calls Change
+$1.63M

Top Buyers

Rank Fund Capital Flow
1
SFA
Sequoia Financial Advisors
Ohio
+$124K

Top Sellers

Rank Fund Capital Flow
1
KJHP
K.J. Harrison & Partners
Ontario, Canada
-$281K
2
PFM
Privium Fund Management
Netherlands
-$158K
3
AC
Armistice Capital
New York
-$3
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$938K -$3 -1 -0%
RAM
2
Redmond Asset Management
Virginia
$188K – – –
KJHP
3
K.J. Harrison & Partners
Ontario, Canada
$172K -$281K -101,865 -60%
PFM
4
Privium Fund Management
Netherlands
$159K -$158K -57,177 -47%
SFA
5
Sequoia Financial Advisors
Ohio
$113K +$124K +45,000 New

BCTXW Hedge Fund Activity: Q2 2023 in Review

5 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in BriaCell Therapeutics Corp Warrant (BCTXW) for Q2 2023, worth a combined $1.57M — down 28% from $2.19M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new BCTXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Sequoia Financial Advisors, opening a new position worth an estimated $124K. The largest seller was K.J. Harrison & Partners, cutting an estimated $281K.

  • 5 institutional investors held BriaCell Therapeutics Corp Warrant (BCTXW) as of Q2 2023, up from 4 in Q1 2023.
  • Funds reported $1.57M of BriaCell Therapeutics Corp Warrant stock for Q2 2023, down 28% quarter-over-quarter.
  • 1 fund opened new BriaCell Therapeutics Corp Warrant positions in Q2 2023 and 0 closed out, a net change of +1 holder.
  • The largest BriaCell Therapeutics Corp Warrant buyer in Q2 2023 was Sequoia Financial Advisors, an estimated $124K added.
  • The largest BriaCell Therapeutics Corp Warrant seller in Q2 2023 was K.J. Harrison & Partners, an estimated $281K sold.

Based on aggregated 13F filings for Q2 2023.